SARS-CoV-2

Latest

SARS-CoV-2

·March 16, 2020·8 min read

NIH Clinical Trial of Investigational Vaccine for COVID-19 Begins

A phase 1 trial evaluating an investigational vaccine designed to protect against COVID-19 has begun in Seattle. The study will enroll 45 healthy people aged 18 to 55, over approximately 6 weeks. The first participant received the investigational vaccine today. Adults in the Seattle area may join the study.

Featured Neuroscience Open Neuroscience Articles

·March 15, 2020·3 min read

Antibodies from COVID-19 survivors could be used to treat patients and protect those at risk

Johns Hopkins University researchers propose using antibodies from the plasma or serum of those who have recovered from COVID-19 to help boost the immunity of newly infected patients and for those at risk of contracting the disease. Researchers say the antibodies may bind to and neutralize SARS-CoV-2. The technique has been proven successful in prior outbreaks, including the SARS epidemic and the 1918 flu pandemic.

Featured Genetics Neuroscience

·March 13, 2020·2 min read

Whole genomes of coronavirus from UK patients sequenced

Researchers have sequenced their first two genomes of COVID-19 from samples of patients in the UK. The genomes have been published on an international viral sequence database. The sequences will provide critical information to track the spread and evolution of the virus in the UK and worldwide.

Featured Neuroscience

·March 13, 2020·3 min read

Coronavirus spreads quickly and sometimes before people have symptoms

The time between cases in a chain of transmission of COVID-19 is less than one week, and more than 10% of patients are infected by someone who has the virus but is not yet symptomatic.

Featured Genetics Neuroscience

·March 13, 2020·7 min read

New COVID-19 diagnostic test could deliver results in less than 30 minutes

MIT researchers are working on a range of projects to help diagnose and slow the transmission of COVID-19. Researchers report they are developing a paper-based COVI-19 test that can deliver results within less than 30 minutes. They are currently submitting to the FDA for emergency use authorization, which would grant temporary approval for using the test on patient samples during public health emergencies. Another research team report they have developed an experimental RNA vaccine that is ready to test.

Featured Neuroscience

·March 13, 2020·1 min read

Research team has isolated the COVID-19 virus

A team of Canadian researchers has isolated SARS-CoV-2, the viral agent responsible for COVID-19. Isolating the virus will help researchers worldwide to develop better diagnostic tests, treatments, and vaccines for the pandemic virus. It will also help researchers to better understand the virus biology, evolution, and viral shedding.

Featured Genetics Neuroscience Open Neuroscience Articles

·March 12, 2020·4 min read

Researchers identify potential targets for immune response to COVID-19

Study provides first potential targets for effective immune responses against COVID-19. The findings provide essential information for vaccine design against SARS-CoV-2.

Featured Neuroscience Open Neuroscience Articles

·March 12, 2020·6 min read

Study details first known person-to-person transmission of new coronavirus in the USA

A new Lancet study describes the first locally-transmitted case of SARS-CoV-2, which causes COVID-19, in the USA from a woman who recently traveled to China and transmitted the infection to her husband.

Featured Neuroscience Open Neuroscience Articles

·March 9, 2020·5 min read

5.1 days incubation period for COVID-19

Researchers report the median time from exposure to symptoms for the COVID-19 virus is 5.1 days. 97.5% of people who develop symptoms of coronavirus will do so within 11.5 days of exposure. For every 10,000 people quarantined for 14 days, an estimated 101 would develop symptoms after release.

1 … 18 19 20

Username
Password

	Remember Me Lost your password?